Diabetes

Tissue Engineering Diabetes Treatments Obesity Epidemic Obesity Management Research Studies Lifestyle Factors Dating Chronic Conditions Neuroscience Market Competition

4 ARTICLES

2h ago

Amgen’s MariTide Delivers 20% Weight Loss in Phase 2 and Advances to 72-Week Phase 3 Trial

Amgen plans a 72-week pivotal study following phase 2 results that showed substantial weight loss alongside lower gastrointestinal side effects from a low-dose ramp-up.

Stories older than 24h

3 ARTICLES

4d ago

Japanese Interval Walking Method Gains TikTok Traction as Low-Impact Fitness Trend

4 ARTICLES

2w ago

Everyday Phytosterol Intake Reduces Heart Disease and Diabetes Risk, Study Finds

3 ARTICLES

3w ago

GLP-1 Drugs Associated with Reduced Obesity-Related Cancer and Mortality Risks

5 ARTICLES

3w ago

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

3 ARTICLES

4w ago

Breakthrough Vascularized Stem Cell Islet Organoids Advance Diabetes Research

8 ARTICLES

4w ago

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

3 ARTICLES

4w ago

Study Highlights GADD45A's Role in Preventing Heart Failure

6 ARTICLES

last mo.

Alison Hammond Details 11-Stone Weight Loss and Lifestyle Transformation

3 ARTICLES

last mo.

Eric Stonestreet Opens Up About Type 2 Diabetes Journey and Mounjaro's Impact

3 ARTICLES

last mo.

Hypnotherapy Ends Father’s 14-Can-a-Day Pepsi Max Habit

4 ARTICLES

last mo.

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

4 ARTICLES

2mo ago

Carnegie Mellon Advances Collagen-Based Bioprinting for Vascularized Tissue Engineering

4 ARTICLES

2mo ago

Mark Andrews Addresses Future as Ravens Weigh Cap Savings Before NFL Draft

4 ARTICLES

2mo ago

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

3 ARTICLES

2mo ago

Type 5 Diabetes Gains Global Recognition as Distinct Disease

3 ARTICLES

2mo ago

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Particle.news

Diabetes

Amgen’s MariTide Delivers 20% Weight Loss in Phase 2 and Advances to 72-Week Phase 3 Trial

Up to Three Cups of Black Coffee a Day Linked to Lower Mortality

ACBP Protein Identified as Brake on Brown Fat Thermogenesis

UVA Artificial Pancreas Employs Digital Twin to Advance Diabetes Control

Japanese Interval Walking Method Gains TikTok Traction as Low-Impact Fitness Trend

Everyday Phytosterol Intake Reduces Heart Disease and Diabetes Risk, Study Finds

GLP-1 Drugs Associated with Reduced Obesity-Related Cancer and Mortality Risks

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

Breakthrough Vascularized Stem Cell Islet Organoids Advance Diabetes Research

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Never miss stories about

Diabetes

Study Highlights GADD45A's Role in Preventing Heart Failure

Alison Hammond Details 11-Stone Weight Loss and Lifestyle Transformation

Eric Stonestreet Opens Up About Type 2 Diabetes Journey and Mounjaro's Impact

Hypnotherapy Ends Father’s 14-Can-a-Day Pepsi Max Habit

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

Carnegie Mellon Advances Collagen-Based Bioprinting for Vascularized Tissue Engineering

Mark Andrews Addresses Future as Ravens Weigh Cap Savings Before NFL Draft

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Type 5 Diabetes Gains Global Recognition as Distinct Disease

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Never miss stories about

Diabetes